Assessing Tricuspid and Mitral Interventions

By Rebecca T. Hahn, MD; Didier Tchétché, MD; and Dominick Angiolillo, MD

From Neglected to Noticed: A Contemporary Understanding of Tricuspid Regurgitation Pathophysiology

Describing the anatomy and physiology of the tricuspid valve apparatus, including the annulus, leaflets, chordae tendineae, and papillary muscles among different types of tricuspid regurgitation.

By Yan Topilsky, MD, and Rebecca T. Hahn, MD, FACC

Treatment Options and Outcomes for Tricuspid Regurgitation

An update on the rapidly evolving landscape of surgical and transcatheter techniques and devices for tricuspid valve disease treatment.

By Gorav Ailawadi, MD, MBA; Charles Davidson, MD; Maurizio Taramasso, MD, PhD; and Marta Sitges Carreño, MD, PhD

Designing Trials for Transcatheter Tricuspid Valve Interventions

Contemporary challenges and opportunities.

By Zachary K. Wegermann, MD, and Sreekanth Vemulapalli, MD

Functional Mitral Regurgitation: Learnings and Limits of the COAPT and MITRA-FR Trials

Possible explanations for the different results between the MITRA-FR and COAPT trials.

By Daniel Grinberg, MD, PhD; Xavier Armoiry, PharmD, PhD; and Jean-François Obadia, MD, PhD

Perspectives on Transcatheter Mitral Therapy

Comparing devices and methods for the treatment of mitral valve regurgitation.

By Marcel Weber, MD; Johanna Vogelhuber, MD; Can Öztürk, MD; Sebastian Zimmer, MD; and Georg Nickenig, MD

The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI

Insight on the role of oral anticoagulation as default antithrombotic strategy after transcatheter aortic valve implantation.

By Antonio Greco, MD, and Davide Capodanno, MD, PhD

Total Cost of Care: Understanding the Economics of Your Program

A discussion on cost comparisons, expert reviews of value-based reimbursement models, and a deep dive into defining total cost of care components for developing transformational cost strategies.

By Ginger Biesbrock, PA-C, MPH, MPAS, FACC

An Interview With Mirvat Alasnag, MD, FACC, FACP, FSCAI, FRCP

Dr. Alasnag discusses her experience as a woman in interventional cardiology, the benefits of mentorship, thoughts on treatment strategies and techniques, and more.